Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274

Benzinga Newsdesk www.benzinga.com Positive 88.3%

Neg 0% Neu 0% Pos 88.3%

Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $251 to $274.